doi: 10.2337/db12-0315 41 AidaKFukuiTJimboEYagihashiSShimadaAOikawaYet al
A phase 3, international, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of glepaglutide in patients with short bowel syndrome (SBS)
Learn about our Supportive & Flexible Outpatient Mental Health Treatment Program Milestone Treatment Center provides outpatient mental health treatment designed to support clients with or without substance use disorder
Most GLP-1 medications are administered once weekly (such as semaglutide and dulaglutide) or once daily (such as liraglutide), and maintaining consistency is important for optimal glycaemic control and minimising side effects
Clinical studies show an average weight loss of 15-20% after one year of treatment
A doctor creates an opening, called a gastrostomy, in your abdominal wall and into your stomach